^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

Therapeutic efficacy of a MMAE-based anti-DR5 drug conjugate Oba01 in preclinical models of pancreatic cancer

Published date:
04/29/2023
Excerpt:
Our data revealed that DR5 was highly expressed on the plasma membrane of PC cells and Oba01 showed potent in vitro antitumor activity in a panel of human DR5-positive PC cell lines.
DOI:
https://doi.org/10.1038/s41419-023-05820-1